Indian pharma firms appointing former USFDA officers to tide over compliance issues

Indian pharmaceutical companies are hiring former US Food and Drug Administration (USFDA) officers to tide over compliance issues. Lupin has hired one such officer, Diana Amador-Toro, as senior vice-president, the company informed shareholders in an

Experts call for using Covid vaccine platforms to successfully manufacture HIV vaccine

Even as highly effective Covid-19 vaccines have been developed in a year, the history of HIV vaccine research has been far less successful. Experts treating HIV/AIDS have called for using DNA and mRNA based Covid vaccine platforms to successfully...

NTAGI likely to review efficacy data of India's first intranasal Covid vaccine

The National Technical Advisory Group on Immunisation (NTAGI) is likely to review safety and efficacy data of India's first intranasal Covid-19 vaccine by Hyderabad-based Bharat Biotech at a meeting slated for this month. "The firm has approached...

Sanofi India assigns Preeti Futnani as General Manager, Vaccines

Sanofi India announced the appointment of Preeti Futnani as the Company’s General Manager – Vaccines, with effect from June 1, 2022. This marks her transition from being the Franchise Head for Dupixent Dermatology at Sanofi’s Greater Gulf MCO...

BDR Pharma, Varenyam launch Sugammadex anaesthesia drugs in India

BDR Pharmaceuticals and Varenyam Healthcare have announced the launch of Sugammadex - an innovative, first of its kind drug in over 10 years with novel γ-cyclodextrin neuromuscular block (NMB) reversal properties. Sugammadex is a pioneer...

Strides Pharma recieves USFDA approval for generic Ibuprofen oral suspension

Strides Pharma Science Ltd (Strides) on Monday said its Singapore-based arm has gets approval from the US health regulator for generic Ibuprofen oral suspension, which is used to relieve pain from various conditions...

Venus Remedies registers 9.22 pc increase annual sales for FY 2021-22

Pharma firm Venus Remedies on Saturday said it has registered a 9.22 per cent increase in annual sales in 2021-22 in comparison to sales in 2020-21. "Aided by concerted efforts to build on its export orders, supply chain, distribution network...

U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients

Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug...

Factors that are Reshaping Pharma Contract Manufacturing

Post the outburst of COVID-19 pandemic, the pharmaceutical sector across the globe sought contract manufacturing in a big way.

Top 5 Technologies that support digital manufacturing of Biologics

The biologics market comprises sales of biologics and related services by entities which include sole traders, partnerships & organizations

© 2025 India Pharma Outlook. All Rights Reserved.